For more than 20 years, 3D has partnered with pharmaceutical, biotech, and medical device companies to prepare for high-stakes interactions and build the skills they need to communicate effectively. 3D’s team is dedicated to transforming complex information into clear and convincing messages and presentations to US and EU regulators, policymakers, payers, key opinion leaders, investors, media, and company executives. 3D’s science, communications, regulatory, and market access experts leverage their proven 3D ACT® process and state-of-the-art technology to help clients deliver with confidence and purpose.